• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about GHRS

    Recent news which mentions GHRS

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Psychedelic Stock Gainers And Losers From January 1, 2024
    Tickers ATAI CMPS CYBN GHRS
    Tags Markets ATAI MNMD
    From Benzinga
    Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
    Tickers ATAI AWKNF CMND CMPS
    Tags RFK SEEL Markets
    From Benzinga
    Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More
    Tickers ATAI CMND CMPS DRUG
    Tags Market News PSIL Psychedelics
    From Benzinga
    Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
    Tickers ATAI BRAXF CMND CMPS
    Tags Market News BRAXF Psychedelics
    From Benzinga
    Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
    Tickers ATAI CMND CMPS CYBN
    Tags ATAI SILO Penny Stocks
    From Benzinga
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
    Tickers ATAI AWKNF CMPS CYBN
    Tags Johns Hopkins Center for Psychedelic and Consciousness Research CMPS CYBN
    From Benzinga
    GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
    Tickers ATAI CMPS CYBN GHRS
    Tags Markets MNMD ATAI
    From Benzinga
    Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Tickers ADSK AGIL AGL ANGH
    Tags HPQ GOTU SPRC
    From Benzinga
    HP, Iridium Communications And Other Big Stocks Moving Higher On Wednesday
    Tickers AGL CLMT GHRS GYRE
    Tags GHRS PAGS Benzinga
    From Benzinga
    GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
    Tickers GHRS
    Tags Earnings Market News financial results
    From Benzinga
    Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
    Tickers ATAI CMPS CYBN DRUG
    Tags PSIL Psychedelics Market News
    From Benzinga
    Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
    Tickers ATAI CMPS CYBN DEA
    Tags CMPS FDA IXHL
    From Benzinga
    Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Psychedelics PSIL Market News
    From Benzinga
    General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday
    Tickers AVXL DB FFIV GD
    Tags Markets News Small Cap
    From Benzinga
    Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
    Tickers ATAI CMPS CYBN DMTTF
    Tags Psychedelic/Assisted Therapies Markets News
    From Benzinga
    Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
    Tickers ATAI CMPS CYBN DMTTF
    Tags ATAI MYCOF Penny Stocks
    From Benzinga
    Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
    Tickers ATAI BNOX CMPS CYBN
    Tags CMPS IXHL CYBN
    From Benzinga
    GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
    Tickers GHRS
    Tags Investigational New Drug Application Psychedelic/Assisted Therapies Markets
    From Benzinga
    Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Psychedelic/Assisted Therapies Markets News
    From Benzinga
    Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Market News PSIL Psychedelics
    From Benzinga
    Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
    Tickers ATAI CMND CMPS DRUG
    Tags Psychedelics PSIL Market News
    From Benzinga
    Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
    Tickers ATAI AWKNF CMND CMPS
    Tags PSIL Psychedelics Market News
    From Benzinga
    Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
    Tickers ATAI BRAXF CMPS CYBN
    Tags Legal Psychedelics Reform DMTTF
    From Benzinga
    Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
    Tickers ATAI CMPS CYBN DRUG
    Tags Benzinga TRUFF GHRS
    From Benzinga
    GH Research Psychedelics Firm Q2 2023 Reports $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
    Tickers GHRS
    Tags Psychedelics Management Market News
    From Benzinga
    Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
    Tickers ATAI CMPS CYBN DRUG
    Tags SCTL Global Legal
    From Benzinga
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    Tickers AGNPF ATAI AWKNF CMPS
    Tags PSIL AGNPF Psychedelics
    From Benzinga
    Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
    Tickers ATAI AWKNF CMPS CYBN
    Tags MNMD Small Cap News
    From Benzinga
    Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
    Tickers ATAI CMPS DMTTF DRUG
    Tags MNMD Small Cap News
    From Benzinga
    The 3 Best Psychedelic Stocks to Buy Now
    Tickers CMPS GHRS MNMD
    Tags NASDAQ:CMPS,NASDAQ:MNMD,NASDAQ:GHRS Market News GHRS
    From InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    12 13 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.